ArticleBMC cardiovascular disorders2025
Microcirculatory resistance index based on a single angiographic view predicts long-term prognosis following rotational atherectomy in patients with acute coronary syndrome.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2026.Cardiovascular intervention and therapeutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo explore the long-term predictive value of the angiographic microcirculatory resistance (AMR) index for patients with acute coronary syndrome (ACS) undergoing rotational atherectomy (RA).
methodsA total of 344 ACS patients undergoing RA during percutaneous coronary intervention (PCI) at Nanjing Drum Tower Hospital between December 1, 2011 and December 1, 2022 were retrospectively analyzed. AMR of the target vessel was measured, and the incidence of major adverse cardiac and cerebral events (MACCEs) was analyzed as the primary endpoints. MACCEs encompassed cardiovascular mortality, non-fatal myocardial infarction (MI), target vessel revascularization (TVR), worsening heart failure (WHF), and ischemic stroke (IS). Patients were divided into the MACCEs group and the non-MACCEs group based on the occurrence of MACCEs. Univariate and multivariate Cox regression analyses were conducted to determine factors linked to MACCEs. Moreover, patients categorized based on the median AMR value into the high-AMR group and the low-AMR group. We conducted Kaplan-Meier curve analysis to assess the differences in the cumulative event rates between patients in the high-AMR group and the low-AMR group during long-term follow-up. Utilizing restricted cubic spline (RCS) curves, we further validated the relationship between AMR and the occurrence of MACCEs.
resultsAfter the completion of a median follow-up time of 39 months, 268 ACS patients undergoing RA were included in the final analysis, of whom 53 (19.78%) experienced MACCEs. Compared with the non-MACCEs group, the MACCEs group exhibited a significantly higher AMR post-RA (P < 0.05). There was no statistically significant difference in clinical presentations between patients in the high-AMR and low-AMR groups. The multivariate Cox regression analysis revealed that AMR following RA was an independent predictor of MACCEs during long-term follow-up (hazard ratio [HR]: 2.364, 95% confidence intervals: 1.394–4.009; P < 0.01). Furthermore, restricted cubic spline analysis revealed a positive correlation between the cumulative risk of primary endpoints and increasing AMR levels. Notably, utilizing AMR as a continuous variable revealed a rapid elevation in HRs for MACCEs within the higher range of AMR (AMR > 2.278) in the long-term.
conclusionsElevated AMR post-RA predicts an increased risk of MACCEs during long-term follow-up in ACS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.